A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

Overview of attention for article published in Neurology, April 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs
policy: 1 policy source
twitter: 21 X users
patent: 1 patent

facebook: 1 Facebook page
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 243 Mendeley

So far, Altmetric has seen 25 X posts from 21 X users, with an upper bound of 155,102 followers.

@DrMario1975 @u110110 @Chloe_bae28 @pschofie79 Now, this is the thing. I don’t wanna see X links. I wanna see pub med, I wanna see NIH, etc.. I will link my favorites below. https://t.co/AVdAkpQaJJ https://t.co/o2i02XqpgT https://t.co/8eYBJYgxkw

@ajlees No, I have loved reading your work over the years. But in this case, actually some of the best evidence is from a large, NIH-supported clinical trial. https://t.co/DODXpa9nz1

Los antidepresivos SSRI no parecen empeorar los sintomas motores del parkinsonismo. http://t.co/5kRa7GuY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.